Eisai/Biogen’s Leqembi Breezes Through Adcomm, Labeling Discussions With US FDA May Be Knottier

 
• By Sue Sutter
Leqembi vials and boxes
• Source: Eisai

More from US FDA Performance Tracker

More from Regulatory Trackers